MENU
ELEV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Elevation Oncology (ELEV) Ownership - Who owns Elevation Oncology?
Profile
Industry
N/A
Address
101 Federal Street
Phone
+1 716 371-1125
Employees
29
Web
https://www.elevationoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.84M
P/E Ratio
N/A
Total Cash
103.07M
Projected Growth
N/A
Total Debt
31.02M
Revenue
N/A
Risk (Beta)
1.07
Dividend Yield
N/A
Total Cash/Share
1.74
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ELEV
Capitalization
37.8M
P/E Ratio
N/A
Risk (Beta)
1.07
Dividend Yield
N/A
Total Cash
103M
Total Cash/Share
1.74
Total Debt
31M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
69.4M
P/B Ratio
0.57
Cash Flow
N/A
Earnings
-0.8
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
17.77
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-43.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.67
Shares Held By Institutions
128M
Shares Outstanding - Current
59.1M
Total Liabilities
36.9M
Total Volume MTD
N/A
Value
1
Gain YTD
24.730
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
101 Federal Street
Phone
+1 716 371-1125
Employees
29
Web
https://www.elevationoncology.com